Hyperphosphataemia after Moxidectin (ProHeart 6) in dogs

219 reports to the FDA describe hyperphosphataemia in dogs given Moxidectin. That is 0.4% of all reports for this medicine, compared with 0.6% across reports for all dog medicines.

219Reports
50%Marked serious
4.6%Recovered
46%Died or euthanised
1 daysTypical onset
SponsoredWorried about your pet? Ask a veterinarian online, 24/7

How soon it started

Same day
44 34%
1–2 days
32 25%
3–7 days
19 15%
1–4 weeks
18 14%
Over a month
15 12%

How the animals did

Recovered
10 4.6%
Still unwell when reported
73 33%
Died
66 30%
Euthanised
35 16%
Not known
35 16%

Problems reported at the same time

Age of the animals

Under 1 year
18
1–3 years
62
4–7 years
59
8–11 years
44
12+ years
33

About this medicine

Moxidectin prevents heartworm disease (monthly topical, or a 6- or 12-month injection for dogs).

Products with this ingredient include ProHeart 6, ProHeart 12. The FDA hides brand names in its public data, so these reports cover every product with the same active ingredients.

Some herding breeds (for example Collies) carry the MDR1 gene variant and can be more sensitive to this drug class at high doses.

Questions owners ask

Can Moxidectin cause hyperphosphataemia in dogs?
219 reports link the two, but a report alone does not prove the medicine was the cause: other illnesses, other medicines or coincidence can be involved. Your vet can judge it for your animal.
How soon after a dose was it reported?
In half of the reports with dates, it started within 1 day of the first dose.
What should I do?
Don't give another dose until you've spoken to your vet, and keep the packaging so you can tell them the product and dose. Your vet can also report it to the FDA (or you can, through the manufacturer or FDA form 1932a).

Hyperphosphataemia with similar medicines

All reported side effects of Moxidectin in dogs · Medicines most reported with hyperphosphataemia